1.Invasive Cervical Cancer in Women Aged 35 or Less.
Eun Hee CHYU ; Won Gue KIM ; Un Dong PARK
Korean Journal of Gynecologic Oncology and Colposcopy 1995;6(1):13-22
The incidence in women less than 35 years of age is increasing despite an overall decrease in newly diagnosed invasive cervieal cancer among all age groups. However the influence of young age on prognosis remains controversial. So 163 patients of invasive cervical cancer in women aged 35 or less treated from Jan. 1, 1984 to Dec. 31. 1993 at the Department of Obstetrics and Gynecology, Kosin Medical College, Pusan, Korea, were studied retrospectively. We obtained the following results; The 5-year survival rates by clinical stage were 88.7Y% in stage I b, 71.5% in stage IIa, 31.2% in stage IIb and O% in stage III or above. The lymph node metastasis rates by stage in RAH group, were 21.3% in stage I b and 31.8% in stage IIa. The lymph nodc metastasis rates by lesion size in RAH group, were 19.2% in 2cm below, 20.7% in 2-4cm and 40.0% in 4cm above. The 5-year survival rates in RAH group were 74,9% in lymph node positive group and 89.0% in lymph node negative group. The recurrenee rates by clinieal stage were 0% in stage Ia, 20.6% in stage I b, 22.2% in stage IIa, 50.0% in stage Ilb and 90.9% in stage III or above.
Busan
;
Female
;
Gynecology
;
Humans
;
Incidence
;
Korea
;
Lymph Nodes
;
Neoplasm Metastasis
;
Obstetrics
;
Prognosis
;
Retrospective Studies
;
Survival Rate
;
Uterine Cervical Neoplasms*
2.Clinical Evaluation of 103 Cases of Adenocarcinoma of the Uterine Cervix.
Seung Hak YANG ; Won Gue KIM ; Un Dong PARK
Korean Journal of Gynecologic Oncology and Colposcopy 1994;5(4):15-23
OBJECTIVE: The purpose of this study was to investigate clinical charactoristics of adenocarcinoma of the uterine cervix. STUDY METHODS: This study is a retrospective analysis of 103 patients with adenocarcinoma of cervix treated at the Kosin Medical center forom 1984 to 1993. RESULTS: The distribution by stage of disease included FIGO stage I, 51(49.6%); stage II, 32(31%); Stage III, 17(16.5%);Stage IV, 3(2.9%). The 2-year survival results for patients with stage I was 93.5%; stage II was 72.4%;stage III was 46.2% and stage IV was none survived. And 4 year survival results,'83.3/o, 591% and 33.3/o in stage I, II and III, reqxetively. The 4-year survivel rate varied significantly according to tumor size and lymph nade metastasis status-below 2cm 84.2%, 2cm~4cm 75%, above 4cm 0%: (stage I);negative node 91.3%, positive node 40% (stage I). The results of resurrent rate according to clinical stage was 11.8%, 25.8%, 84.6% and 100 % in stage I, ll, III and lV, respectively. CONCLUSION: Treatment strategies should be based on the stage of disease, tumor size, lymph node metastasis status and recurrent.
Adenocarcinoma*
;
Cervix Uteri*
;
Female
;
Humans
;
Lymph Nodes
;
Neoplasm Metastasis
;
Retrospective Studies
3.Tetraparesis in ossification of the posterior longitudinal ligament of the cervical spine.
Sung Joon KIM ; Jae Lim CHO ; Gue Ho BAE
The Journal of the Korean Orthopaedic Association 1993;28(2):588-593
No abstract available.
Longitudinal Ligaments*
;
Spine*
4.The effects of insulin-like growth factors on the proliferation of endometrial stromal cells from patients with and without endometriosis.
Myung Hee KIM ; Gue Wha LEE ; Yong Hee LEE ; Jung Gu KIM
Korean Journal of Obstetrics and Gynecology 2000;43(2):286-294
OBJECTIVES: To test the hypothesis that the endometrial stromal cells from patients with endometriosis responds differently to the insulin-like growth factor (IGF) compared with those from patients without endometriosis. METHODS: IGFs in peritoneal fluid (PF) from patients with endometriosis(n=18) and without endometriosis(n=12;control patients) were measured by radioimmunoassay. Endometrial stromal cells from patients with endometriosis and control patients were cultured in serum free media(SFM) in the presence or absence of PF or IGF-I(0.25-25 ng/ml) or IGF-II(5-50 ng/ml) and the proliferation of endometrial stromal cells were evaluated by [3H] thymidine incorporation test. All statistics were performed by ANOVA test and student's t-test. RESULTS: When added to SFM, IGF-I(1-25 ng/ml) increased thymidine incorporation in both endometrial stromal cells from patients with endometriosis and control patients in dose dependent manner and IGF-II(5-25 ng/ml) gave similar response in latter cells but not in former cells. Within low IGF-I(less than 100 ng/ml) PF group or high IGF-I(more than 100ng/ml) PF group, the type of endometrial stromal cells did not result in any difference in thymidine incorporation. However, regardless of the source of stromal cells, high IGF-I PF group produced a greater extent of thymidine incorporation than low IGF-I PF group in patients with endometriosis but not in control patients. Also, thymidine incorporation was higher in high IGF-I PF group of former patients than in the same group of latter patients. PF induced higher thymidine incorporation in endometrial stromal cells than the same levels(0.25-2.5 ng/ml) of IGF-I directly added to SFM. CONCLUSIONS: The effects of IGF-I in PF on endometrial stromal cells are similar regardless of their source and IGF-I is one of several growth factors that may participate in the growth of endometrial stromal cells in pelvic endometriosis.
Ascitic Fluid
;
DNA
;
Endometriosis*
;
Female
;
Humans
;
Insulin-Like Growth Factor I
;
Intercellular Signaling Peptides and Proteins
;
Radioimmunoassay
;
Somatomedins*
;
Stromal Cells*
;
Thymidine
5.A case of orbital Polyarteritis Nodosa Complicated with Retinal Vasculitis and Exophthalmos.
Hyun Gue KIM ; Su Hyung LEE ; In Taek KIM
Journal of the Korean Ophthalmological Society 2003;44(1):215-219
PURPOSE: Polyarteritis nodosa is a necrotizing vasculitis affecting medium and small sized arteries throughout the vascular system, including ocular tissues. We report a case of orbital polyarteritis nodosa complicated with retinal vasculitis and exophthalmos. METHODS: A 51-year-old woman complained of swelling and hard mass in periorbital region for 3 months. The left eye was anophthalmos after enucleation secondary to corneal infection. The patient has treated marginal ulcer of the cornea and keratomalacia. Posterior synechia and motility disturbance of lateral rectus muscle were also revealed. Fundus examination showed focal retinal hemorrhage, macular hard exudate, and soft exudate, which may mean retinal vasculitis. Both eyes gradually developed exophthalmos. Orbital CT scan revealed homogenous infiltration in the orbit, ethmoid bone, and nasal cavity and perforation of the nasal septum. The pathologic examination for the biopsy specimen from the orbital tissue demonstrated a nongranulomatous vasculitis, diagnosing the polyarteritis nodosa. RESULTS: The authors present ocular manifestations, including marginal corneal ulcer, keratomalacia, dysfunction of the extraocular muscles, posterior synechia, retinal hemorrhage, soft exudate, hard exdate in the macula, and exophthalmos, in this patient with the polyarteritis nodosa.
Anophthalmos
;
Arteries
;
Biopsy
;
Cornea
;
Corneal Ulcer
;
Ethmoid Bone
;
Exophthalmos*
;
Exudates and Transudates
;
Female
;
Humans
;
Middle Aged
;
Muscles
;
Nasal Cavity
;
Nasal Septum
;
Orbit*
;
Peptic Ulcer
;
Polyarteritis Nodosa*
;
Retinal Hemorrhage
;
Retinal Vasculitis*
;
Retinaldehyde*
;
Tomography, X-Ray Computed
;
Vasculitis
6.Surgical Results of Meralgia Paresthetica.
Journal of Korean Neurosurgical Society 2004;35(2):188-191
OBJECTIVE: Meralgia Paresthetica is an entrapment neuropathy involving the lateral femoral cutaneous nerve. The aim of the present study is to evalute results of two surgical procedures(neurolysis and transection) for this disease. METHODS: The authors reviewed the 11 patients who underwent surgery in our hospital for meralgia paresthetica for last 15 years. Preoperatively all patients were treated by conservative management which was failed. Visual analogue scale(VAS) sore was used for pre-and post-operative assessments of the pain. Operation is performed by infrainguinal ligament approach. Nine patients underwent neurolysis, and two patients underwent transection of the lateral femoral cutaneous nerve. The average follow-up period was 14.3 months. RESULTS: In 10 cases good relief of symptom was obtained, but in one case relief of symptom was not. Superior result of transection as a treatment for meralgia paresthetica was obtained. But, there was no statistically significant difference between two procedures because of small group. CONCLUSION: When surgery is indicated for patients in whom pain is severe and persistent despite adequate conserative management, it appears to offer good results.
Follow-Up Studies
;
Humans
;
Ligaments
7.The alteration of p16 protein in invasive cervical cancer.
Korean Journal of Obstetrics and Gynecology 2002;45(4):602-609
OBJECTIVE: Recently p16 gene has been found as a new factor for cervical carcinogenesis. The purpose of this study is to investigate the p16 protein alteration in invasive cervical cancers, and to find the correlation with the p53 protein overexpression, HPV infection and the clinicopathologic prognostic parameters, as well as to predict the prognosis by examining the influences of the p16 gene, p53 gene, HPV to the survival rate. MATERIAL & METHODS: We examined 29 invasive cervical cancer patients who visited and operated in Obstetrics & Gynecology department of Kosin University Gospel Hospital from Jan. 1994 to Dec. 1995. We investigated clinicopathologic parameters and p16 protein alteration, p53 protein overexpression, HPV 16, 18 infection in these patients. p16 protein and p53 protein were examined by immunohistochemistry method and HPV was done by PCR method. The survival rate was examined by Kaplan-Meier method. RESULTS: The rate of p16 protein alteration, p53 protein overexpression, HPV infection were respectively 31% (9/29), 72.4% (21/29), 80.6% (26/29), and all of these factors had no statistical correlations with the clinicopathologic parameters (p>0.05).Among the 21 positive cases for p53 protein overexpression, p16 protein alteration was positive in 6 (28.6%), negative in 15 (71.4%) cases and among the 8 negative cases for p53 overexpression, p16 showed positive in 3 (37.5%), negative in 5 (62.5%). Finally among the 26 positive cases of HPV infection, p16 alteration was positive in 9 (34.6%) and negative in 17 (65.4%) and all of the 3 HPV infection negative cases showed no p16 alteration. The p16 alteration had no significant correlation with the p53 overexpression and HPV infection.The total 5 years survival rate in 29 cases of invasive cervical cancer patients was 86.2%. In the negative group of p16 protein alteration the survival rate was 80% and the positive group was all alive. In the positive groups of p53 protein overexpression and HPV infection the survival rate were 80.9% and 84.6% respectively and the negative groups were all alive. And these factors had no significant correlation with the survival rates. CONCLUSION: This results indicate that p16 protein alteration had no correlation with clinicopathologic prognostic parameters and survival rates in invasive cervical cancer. In addition p16 protein alteration had no correlation with p53 protein overexpression and HPV infection respectively.
Carcinogenesis
;
Genes, p16
;
Genes, p53
;
Gynecology
;
Human papillomavirus 16
;
Humans
;
Immunohistochemistry
;
Obstetrics
;
Polymerase Chain Reaction
;
Prognosis
;
Survival Rate
;
Uterine Cervical Neoplasms*
8.10 Year's Expreience on Gestational Trophoblastic Disease.
Eun Hee CHYU ; Gun Sang YOO ; Won Gue KIM ; Un Dong PARK
Korean Journal of Gynecologic Oncology and Colposcopy 1996;7(2):84-92
For the clinical analysis and evaluation on the patients with gestational trophoblastic disease(GTD), a study was done retrospectively on 114 patients with GTD(60 in Hydatidiform mole, 10 in invasive mole, 44 in choriocarcinoma) treated from Jan. 1, 1985 to Dec. 31, 1994 at the Department of Obstetrics and Gynecology, Kosin Medical College, Pusan, Korea. We obtained the following results ; The incidence of GTD was 1 per 73 deliveries in H. mole, 1 per 437 deliveries in invasive mole, and 1 per 99 deliveries in choriocarcinoma. The most prevalent age was 21-40 groups. Abnormal vaginal bleeding was a main symptom and sign. 30.6% of H. mole was managed by dilatation and curettage. 90.0% of invasive mole and 51.4% of choriocarcinoma were managed by surgical treatment and chemotherapy. The overall remissinon rate of choriocarcinoma was 71.4%(100.0% in stage I, 66.7% in stage II, 54.5% in stage III, 50.0% in stage IV).
Busan
;
Choriocarcinoma
;
Dilatation and Curettage
;
Drug Therapy
;
Female
;
Gestational Trophoblastic Disease*
;
Gynecology
;
Humans
;
Hydatidiform Mole
;
Hydatidiform Mole, Invasive
;
Incidence
;
Korea
;
Obstetrics
;
Pregnancy
;
Retrospective Studies
;
Trophoblasts
;
Uterine Hemorrhage
9.The application of TD (Touch-Down) PCR in Diagnosis of leprosy and Detection of MDT-resistant M. leprae.
Se Kon KIM ; Seong Beom LEE ; Tae Jin KANG ; Gue Tae CHAE
Korean Leprosy Bulletin 2001;34(2):13-21
There are several methods for diagnosis of leprosy, including AFB stain, the measurement of PGL-1 (phenolic glycolipid - 1) antigen titer, and DNA-PCR. In this study, we have used the DNA-PCR amplifying the RLEP repetitive sequence. Our result showed that the RLEP primer offered the more sensitive detection and identification of M. leprae DNA in clinical specimens, compared with the other primer, for example, 18-kDa antigen gene. To screen the resistant M. leprae strain of MDT (Multi-Drug Therapy), we have used the TD (Touch-Down) PCR. We arranged and amplified sequences of the genes, folP, rpoB, gyr, 23S rRNA, in M. leprae involved in MDT-resistance, and could obtain the PCR product each gene, simultaneously. This method, based on annealing temperature, was useful to the detection for diagnosis and the screen of MDT-resistant strain of M. leprae, rapidly. Thus, we suggest that the RLEP primer and TD-PCR method are effective in assessing the diagnosis of leprosy and the identification of drug-resistant M. leprae.
Diagnosis*
;
DNA
;
Leprosy*
;
Polymerase Chain Reaction*
;
Repetitive Sequences, Nucleic Acid
10.Intraperitoneal cisplatin chemotherapy for advanced ovarian cancer.
Ji Wook PARK ; Chan Hwa MOON ; Won Gue KIM ; Un Dong PARK
Korean Journal of Obstetrics and Gynecology 1993;36(10):3635-3641
No abstract available.
Cisplatin*
;
Drug Therapy*
;
Ovarian Neoplasms*